nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—ABCB1—ovarian cancer	0.238	1	CbGaD
Pimozide—CYP3A7—Paclitaxel—ovarian cancer	0.0398	0.0991	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0398	0.0991	CbGbCtD
Pimozide—ABCB1—Topotecan—ovarian cancer	0.0392	0.0977	CbGbCtD
Pimozide—CYP3A5—Paclitaxel—ovarian cancer	0.0298	0.0743	CbGbCtD
Pimozide—CYP3A7—Docetaxel—ovarian cancer	0.0287	0.0716	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0287	0.0716	CbGbCtD
Pimozide—ABCB1—Vinorelbine—ovarian cancer	0.0276	0.0688	CbGbCtD
Pimozide—CYP2D6—Vinorelbine—ovarian cancer	0.026	0.0649	CbGbCtD
Pimozide—CYP3A4—Topotecan—ovarian cancer	0.0235	0.0585	CbGbCtD
Pimozide—CYP3A5—Docetaxel—ovarian cancer	0.0216	0.0537	CbGbCtD
Pimozide—ABCB1—Paclitaxel—ovarian cancer	0.0194	0.0484	CbGbCtD
Pimozide—CYP3A4—Vinorelbine—ovarian cancer	0.0166	0.0412	CbGbCtD
Pimozide—ABCB1—Docetaxel—ovarian cancer	0.014	0.035	CbGbCtD
Pimozide—CYP3A4—Paclitaxel—ovarian cancer	0.0116	0.029	CbGbCtD
Pimozide—ABCB1—Doxorubicin—ovarian cancer	0.0105	0.0261	CbGbCtD
Pimozide—CYP2D6—Doxorubicin—ovarian cancer	0.00986	0.0246	CbGbCtD
Pimozide—CYP3A4—Docetaxel—ovarian cancer	0.00841	0.0209	CbGbCtD
Pimozide—CYP3A4—Doxorubicin—ovarian cancer	0.00627	0.0156	CbGbCtD
Pimozide—CALM2—oviduct—ovarian cancer	0.00396	0.0545	CbGeAlD
Pimozide—HTR2A—vein—ovarian cancer	0.00391	0.0537	CbGeAlD
Pimozide—CACNA1G—decidua—ovarian cancer	0.00287	0.0394	CbGeAlD
Pimozide—CALM3—myometrium—ovarian cancer	0.00161	0.0222	CbGeAlD
Pimozide—OPRK1—female reproductive system—ovarian cancer	0.00143	0.0197	CbGeAlD
Pimozide—CALM2—myometrium—ovarian cancer	0.00127	0.0174	CbGeAlD
Pimozide—CALM1—myometrium—ovarian cancer	0.00126	0.0174	CbGeAlD
Pimozide—CALM3—uterine cervix—ovarian cancer	0.00126	0.0173	CbGeAlD
Pimozide—CALM2—embryo—ovarian cancer	0.00122	0.0168	CbGeAlD
Pimozide—CALM1—embryo—ovarian cancer	0.00121	0.0167	CbGeAlD
Pimozide—CALM3—decidua—ovarian cancer	0.0012	0.0165	CbGeAlD
Pimozide—KCNH2—myometrium—ovarian cancer	0.00115	0.0158	CbGeAlD
Pimozide—CALM3—endometrium—ovarian cancer	0.00114	0.0156	CbGeAlD
Pimozide—CALM3—uterus—ovarian cancer	0.00105	0.0144	CbGeAlD
Pimozide—CALM2—epithelium—ovarian cancer	0.000995	0.0137	CbGeAlD
Pimozide—CALM1—epithelium—ovarian cancer	0.000991	0.0136	CbGeAlD
Pimozide—CALM2—uterine cervix—ovarian cancer	0.000987	0.0136	CbGeAlD
Pimozide—CALM1—uterine cervix—ovarian cancer	0.000982	0.0135	CbGeAlD
Pimozide—CALM2—decidua—ovarian cancer	0.00094	0.0129	CbGeAlD
Pimozide—CALM1—decidua—ovarian cancer	0.000936	0.0129	CbGeAlD
Pimozide—HRH1—myometrium—ovarian cancer	0.000921	0.0127	CbGeAlD
Pimozide—KCNH2—uterine cervix—ovarian cancer	0.000894	0.0123	CbGeAlD
Pimozide—CALM2—endometrium—ovarian cancer	0.000892	0.0123	CbGeAlD
Pimozide—CALM3—bone marrow—ovarian cancer	0.000889	0.0122	CbGeAlD
Pimozide—CALM1—endometrium—ovarian cancer	0.000888	0.0122	CbGeAlD
Pimozide—CALM3—female gonad—ovarian cancer	0.000857	0.0118	CbGeAlD
Pimozide—CALM3—vagina—ovarian cancer	0.000851	0.0117	CbGeAlD
Pimozide—CALM2—gonad—ovarian cancer	0.000828	0.0114	CbGeAlD
Pimozide—CALM1—gonad—ovarian cancer	0.000824	0.0113	CbGeAlD
Pimozide—CALM2—uterus—ovarian cancer	0.000822	0.0113	CbGeAlD
Pimozide—OPRM1—testis—ovarian cancer	0.000822	0.0113	CbGeAlD
Pimozide—CALM1—uterus—ovarian cancer	0.000819	0.0113	CbGeAlD
Pimozide—KCNH2—endometrium—ovarian cancer	0.000808	0.0111	CbGeAlD
Pimozide—CALM3—testis—ovarian cancer	0.00076	0.0104	CbGeAlD
Pimozide—KCNH2—uterus—ovarian cancer	0.000745	0.0102	CbGeAlD
Pimozide—HTR2A—embryo—ovarian cancer	0.00074	0.0102	CbGeAlD
Pimozide—CALM2—female reproductive system—ovarian cancer	0.000739	0.0102	CbGeAlD
Pimozide—CYP3A5—uterine cervix—ovarian cancer	0.000738	0.0101	CbGeAlD
Pimozide—CALM1—female reproductive system—ovarian cancer	0.000736	0.0101	CbGeAlD
Pimozide—HRH1—epithelium—ovarian cancer	0.000723	0.00994	CbGeAlD
Pimozide—HRH1—uterine cervix—ovarian cancer	0.000716	0.00985	CbGeAlD
Pimozide—CALM2—bone marrow—ovarian cancer	0.000698	0.0096	CbGeAlD
Pimozide—CALM1—bone marrow—ovarian cancer	0.000695	0.00955	CbGeAlD
Pimozide—HRH1—decidua—ovarian cancer	0.000683	0.00939	CbGeAlD
Pimozide—CALM2—female gonad—ovarian cancer	0.000673	0.00925	CbGeAlD
Pimozide—KCNH2—female reproductive system—ovarian cancer	0.00067	0.00921	CbGeAlD
Pimozide—CALM1—female gonad—ovarian cancer	0.00067	0.00921	CbGeAlD
Pimozide—CALM2—vagina—ovarian cancer	0.000669	0.00919	CbGeAlD
Pimozide—CALM1—vagina—ovarian cancer	0.000666	0.00915	CbGeAlD
Pimozide—HRH1—endometrium—ovarian cancer	0.000648	0.00891	CbGeAlD
Pimozide—CYP2C19—vagina—ovarian cancer	0.000635	0.00873	CbGeAlD
Pimozide—KCNH2—bone marrow—ovarian cancer	0.000632	0.00869	CbGeAlD
Pimozide—KCNH2—female gonad—ovarian cancer	0.000609	0.00838	CbGeAlD
Pimozide—KCNH2—vagina—ovarian cancer	0.000606	0.00833	CbGeAlD
Pimozide—HTR2A—epithelium—ovarian cancer	0.000603	0.0083	CbGeAlD
Pimozide—CALM2—testis—ovarian cancer	0.000597	0.0082	CbGeAlD
Pimozide—CALM1—testis—ovarian cancer	0.000594	0.00817	CbGeAlD
Pimozide—CALM3—lymph node—ovarian cancer	0.000551	0.00757	CbGeAlD
Pimozide—DRD2—testis—ovarian cancer	0.000549	0.00754	CbGeAlD
Pimozide—KCNH2—testis—ovarian cancer	0.00054	0.00743	CbGeAlD
Pimozide—HRH1—female reproductive system—ovarian cancer	0.000537	0.00738	CbGeAlD
Pimozide—CYP2E1—female reproductive system—ovarian cancer	0.000516	0.00709	CbGeAlD
Pimozide—ABCB1—myometrium—ovarian cancer	0.000504	0.00693	CbGeAlD
Pimozide—CYP3A5—female gonad—ovarian cancer	0.000503	0.00692	CbGeAlD
Pimozide—HTR2A—gonad—ovarian cancer	0.000502	0.0069	CbGeAlD
Pimozide—CYP3A5—vagina—ovarian cancer	0.0005	0.00688	CbGeAlD
Pimozide—HRH1—female gonad—ovarian cancer	0.000488	0.00672	CbGeAlD
Pimozide—HRH1—vagina—ovarian cancer	0.000485	0.00668	CbGeAlD
Pimozide—ABCB1—embryo—ovarian cancer	0.000485	0.00666	CbGeAlD
Pimozide—Astemizole—ABCB1—ovarian cancer	0.000458	0.297	CrCbGaD
Pimozide—Ezetimibe—ABCB1—ovarian cancer	0.000458	0.297	CrCbGaD
Pimozide—HTR2A—female reproductive system—ovarian cancer	0.000448	0.00616	CbGeAlD
Pimozide—HRH1—testis—ovarian cancer	0.000433	0.00596	CbGeAlD
Pimozide—CALM2—lymph node—ovarian cancer	0.000432	0.00595	CbGeAlD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.000432	0.00302	CcSEcCtD
Pimozide—CALM1—lymph node—ovarian cancer	0.00043	0.00592	CbGeAlD
Pimozide—Decreased appetite—Topotecan—ovarian cancer	0.000424	0.00296	CcSEcCtD
Pimozide—Aplastic anaemia—Epirubicin—ovarian cancer	0.000422	0.00295	CcSEcCtD
Pimozide—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000421	0.00294	CcSEcCtD
Pimozide—Dysphagia—Docetaxel—ovarian cancer	0.000418	0.00292	CcSEcCtD
Pimozide—Constipation—Topotecan—ovarian cancer	0.000417	0.00291	CcSEcCtD
Pimozide—CYP2E1—testis—ovarian cancer	0.000416	0.00572	CbGeAlD
Pimozide—Ventricular tachycardia—Doxorubicin—ovarian cancer	0.000416	0.00291	CcSEcCtD
Pimozide—Decreased appetite—Melphalan—ovarian cancer	0.000415	0.0029	CcSEcCtD
Pimozide—CYP3A4—female reproductive system—ovarian cancer	0.000415	0.00571	CbGeAlD
Pimozide—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000412	0.00288	CcSEcCtD
Pimozide—Abnormal dreams—Doxorubicin—ovarian cancer	0.000411	0.00287	CcSEcCtD
Pimozide—Nervous system disorder—Vinorelbine—ovarian cancer	0.000409	0.00286	CcSEcCtD
Pimozide—Eructation—Doxorubicin—ovarian cancer	0.000409	0.00285	CcSEcCtD
Pimozide—CYP2D6—female reproductive system—ovarian cancer	0.000408	0.00562	CbGeAlD
Pimozide—Tachycardia—Vinorelbine—ovarian cancer	0.000407	0.00284	CcSEcCtD
Pimozide—HTR2A—vagina—ovarian cancer	0.000405	0.00557	CbGeAlD
Pimozide—Skin disorder—Vinorelbine—ovarian cancer	0.000405	0.00283	CcSEcCtD
Pimozide—Salivary hypersecretion—Doxorubicin—ovarian cancer	0.000404	0.00282	CcSEcCtD
Pimozide—Anorexia—Vinorelbine—ovarian cancer	0.000398	0.00278	CcSEcCtD
Pimozide—Pancytopenia—Docetaxel—ovarian cancer	0.000397	0.00277	CcSEcCtD
Pimozide—ABCB1—epithelium—ovarian cancer	0.000395	0.00544	CbGeAlD
Pimozide—Asthenia—Chlorambucil—ovarian cancer	0.000393	0.00274	CcSEcCtD
Pimozide—ABCB1—uterine cervix—ovarian cancer	0.000392	0.00539	CbGeAlD
Pimozide—KCNH2—lymph node—ovarian cancer	0.000392	0.00539	CbGeAlD
Pimozide—Aplastic anaemia—Doxorubicin—ovarian cancer	0.000391	0.00273	CcSEcCtD
Pimozide—Hypotension—Vinorelbine—ovarian cancer	0.00039	0.00272	CcSEcCtD
Pimozide—Connective tissue disorder—Paclitaxel—ovarian cancer	0.000388	0.00271	CcSEcCtD
Pimozide—Pruritus—Chlorambucil—ovarian cancer	0.000388	0.00271	CcSEcCtD
Pimozide—Urticaria—Topotecan—ovarian cancer	0.000388	0.00271	CcSEcCtD
Pimozide—Weight increased—Docetaxel—ovarian cancer	0.000381	0.00266	CcSEcCtD
Pimozide—Visual impairment—Paclitaxel—ovarian cancer	0.000381	0.00266	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00038	0.00265	CcSEcCtD
Pimozide—Urticaria—Melphalan—ovarian cancer	0.000379	0.00265	CcSEcCtD
Pimozide—Weight decreased—Docetaxel—ovarian cancer	0.000378	0.00264	CcSEcCtD
Pimozide—Diarrhoea—Chlorambucil—ovarian cancer	0.000375	0.00262	CcSEcCtD
Pimozide—ABCB1—decidua—ovarian cancer	0.000374	0.00514	CbGeAlD
Pimozide—CYP2D6—female gonad—ovarian cancer	0.000372	0.00511	CbGeAlD
Pimozide—Eye disorder—Paclitaxel—ovarian cancer	0.000369	0.00258	CcSEcCtD
Pimozide—Cardiac disorder—Paclitaxel—ovarian cancer	0.000367	0.00256	CcSEcCtD
Pimozide—Decreased appetite—Vinorelbine—ovarian cancer	0.000363	0.00253	CcSEcCtD
Pimozide—HTR2A—testis—ovarian cancer	0.000362	0.00497	CbGeAlD
Pimozide—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00036	0.00252	CcSEcCtD
Pimozide—Constipation—Vinorelbine—ovarian cancer	0.000357	0.00249	CcSEcCtD
Pimozide—ABCB1—endometrium—ovarian cancer	0.000355	0.00488	CbGeAlD
Pimozide—Asthenia—Topotecan—ovarian cancer	0.00035	0.00244	CcSEcCtD
Pimozide—Vomiting—Chlorambucil—ovarian cancer	0.000348	0.00243	CcSEcCtD
Pimozide—Agranulocytosis—Docetaxel—ovarian cancer	0.000348	0.00243	CcSEcCtD
Pimozide—Increased appetite—Epirubicin—ovarian cancer	0.000347	0.00243	CcSEcCtD
Pimozide—Mental disorder—Paclitaxel—ovarian cancer	0.000346	0.00242	CcSEcCtD
Pimozide—Pruritus—Topotecan—ovarian cancer	0.000345	0.00241	CcSEcCtD
Pimozide—Asthenia—Melphalan—ovarian cancer	0.000343	0.00239	CcSEcCtD
Pimozide—Pruritus—Melphalan—ovarian cancer	0.000338	0.00236	CcSEcCtD
Pimozide—Diarrhoea—Topotecan—ovarian cancer	0.000334	0.00233	CcSEcCtD
Pimozide—Urticaria—Vinorelbine—ovarian cancer	0.000332	0.00231	CcSEcCtD
Pimozide—Muscle spasms—Paclitaxel—ovarian cancer	0.000331	0.00231	CcSEcCtD
Pimozide—CYP2D6—testis—ovarian cancer	0.00033	0.00453	CbGeAlD
Pimozide—Connective tissue disorder—Docetaxel—ovarian cancer	0.000329	0.0023	CcSEcCtD
Pimozide—ABCB1—gonad—ovarian cancer	0.000329	0.00452	CbGeAlD
Pimozide—Hyponatraemia—Epirubicin—ovarian cancer	0.000328	0.00229	CcSEcCtD
Pimozide—Diarrhoea—Melphalan—ovarian cancer	0.000327	0.00228	CcSEcCtD
Pimozide—ABCB1—uterus—ovarian cancer	0.000327	0.00449	CbGeAlD
Pimozide—Fexofenadine—ABCB1—ovarian cancer	0.000327	0.212	CrCbGaD
Pimozide—Nausea—Chlorambucil—ovarian cancer	0.000325	0.00227	CcSEcCtD
Pimozide—Vision blurred—Paclitaxel—ovarian cancer	0.000324	0.00226	CcSEcCtD
Pimozide—Visual impairment—Docetaxel—ovarian cancer	0.000323	0.00225	CcSEcCtD
Pimozide—Dizziness—Topotecan—ovarian cancer	0.000323	0.00225	CcSEcCtD
Pimozide—Tremor—Paclitaxel—ovarian cancer	0.000322	0.00225	CcSEcCtD
Pimozide—Increased appetite—Doxorubicin—ovarian cancer	0.000322	0.00224	CcSEcCtD
Pimozide—Anaemia—Paclitaxel—ovarian cancer	0.000318	0.00222	CcSEcCtD
Pimozide—Agitation—Paclitaxel—ovarian cancer	0.000316	0.00221	CcSEcCtD
Pimozide—HRH1—lymph node—ovarian cancer	0.000314	0.00432	CbGeAlD
Pimozide—Eye disorder—Docetaxel—ovarian cancer	0.000313	0.00218	CcSEcCtD
Pimozide—Cardiac disorder—Docetaxel—ovarian cancer	0.000311	0.00217	CcSEcCtD
Pimozide—Vomiting—Topotecan—ovarian cancer	0.00031	0.00217	CcSEcCtD
Pimozide—Syncope—Paclitaxel—ovarian cancer	0.000308	0.00215	CcSEcCtD
Pimozide—Leukopenia—Paclitaxel—ovarian cancer	0.000308	0.00215	CcSEcCtD
Pimozide—Rash—Topotecan—ovarian cancer	0.000308	0.00215	CcSEcCtD
Pimozide—Dermatitis—Topotecan—ovarian cancer	0.000307	0.00215	CcSEcCtD
Pimozide—Headache—Topotecan—ovarian cancer	0.000306	0.00213	CcSEcCtD
Pimozide—Palpitations—Paclitaxel—ovarian cancer	0.000304	0.00212	CcSEcCtD
Pimozide—Vomiting—Melphalan—ovarian cancer	0.000304	0.00212	CcSEcCtD
Pimozide—Hyponatraemia—Doxorubicin—ovarian cancer	0.000303	0.00212	CcSEcCtD
Pimozide—Loss of consciousness—Paclitaxel—ovarian cancer	0.000302	0.00211	CcSEcCtD
Pimozide—Rash—Melphalan—ovarian cancer	0.000301	0.0021	CcSEcCtD
Pimozide—Dermatitis—Melphalan—ovarian cancer	0.000301	0.0021	CcSEcCtD
Pimozide—Asthenia—Vinorelbine—ovarian cancer	0.000299	0.00209	CcSEcCtD
Pimozide—Orthostatic hypotension—Epirubicin—ovarian cancer	0.000298	0.00208	CcSEcCtD
Pimozide—Convulsion—Paclitaxel—ovarian cancer	0.000298	0.00208	CcSEcCtD
Pimozide—Domperidone—ABCB1—ovarian cancer	0.000298	0.193	CrCbGaD
Pimozide—Hypertension—Paclitaxel—ovarian cancer	0.000297	0.00207	CcSEcCtD
Pimozide—Pruritus—Vinorelbine—ovarian cancer	0.000295	0.00206	CcSEcCtD
Pimozide—Breast disorder—Epirubicin—ovarian cancer	0.000295	0.00206	CcSEcCtD
Pimozide—ABCB1—female reproductive system—ovarian cancer	0.000294	0.00404	CbGeAlD
Pimozide—Mental disorder—Docetaxel—ovarian cancer	0.000293	0.00205	CcSEcCtD
Pimozide—Chest pain—Paclitaxel—ovarian cancer	0.000293	0.00204	CcSEcCtD
Pimozide—Myalgia—Paclitaxel—ovarian cancer	0.000293	0.00204	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000291	0.00203	CcSEcCtD
Pimozide—Nausea—Topotecan—ovarian cancer	0.00029	0.00202	CcSEcCtD
Pimozide—Dry mouth—Paclitaxel—ovarian cancer	0.000286	0.002	CcSEcCtD
Pimozide—Diarrhoea—Vinorelbine—ovarian cancer	0.000286	0.00199	CcSEcCtD
Pimozide—Nausea—Melphalan—ovarian cancer	0.000284	0.00198	CcSEcCtD
Pimozide—Dysphagia—Epirubicin—ovarian cancer	0.000282	0.00197	CcSEcCtD
Pimozide—Muscle spasms—Docetaxel—ovarian cancer	0.00028	0.00196	CcSEcCtD
Pimozide—Eosinophilia—Epirubicin—ovarian cancer	0.000279	0.00195	CcSEcCtD
Pimozide—ABCB1—bone marrow—ovarian cancer	0.000277	0.00381	CbGeAlD
Pimozide—Shock—Paclitaxel—ovarian cancer	0.000276	0.00193	CcSEcCtD
Pimozide—Dizziness—Vinorelbine—ovarian cancer	0.000276	0.00193	CcSEcCtD
Pimozide—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000276	0.00193	CcSEcCtD
Pimozide—Nervous system disorder—Paclitaxel—ovarian cancer	0.000275	0.00192	CcSEcCtD
Pimozide—Tachycardia—Paclitaxel—ovarian cancer	0.000274	0.00191	CcSEcCtD
Pimozide—Breast disorder—Doxorubicin—ovarian cancer	0.000273	0.00191	CcSEcCtD
Pimozide—Skin disorder—Paclitaxel—ovarian cancer	0.000273	0.0019	CcSEcCtD
Pimozide—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000271	0.00189	CcSEcCtD
Pimozide—Anaemia—Docetaxel—ovarian cancer	0.000269	0.00188	CcSEcCtD
Pimozide—Pancytopenia—Epirubicin—ovarian cancer	0.000268	0.00187	CcSEcCtD
Pimozide—Anorexia—Paclitaxel—ovarian cancer	0.000268	0.00187	CcSEcCtD
Pimozide—ABCB1—female gonad—ovarian cancer	0.000267	0.00368	CbGeAlD
Pimozide—ABCB1—vagina—ovarian cancer	0.000266	0.00365	CbGeAlD
Pimozide—Vomiting—Vinorelbine—ovarian cancer	0.000265	0.00185	CcSEcCtD
Pimozide—Rash—Vinorelbine—ovarian cancer	0.000263	0.00184	CcSEcCtD
Pimozide—Dermatitis—Vinorelbine—ovarian cancer	0.000263	0.00184	CcSEcCtD
Pimozide—Hypotension—Paclitaxel—ovarian cancer	0.000262	0.00183	CcSEcCtD
Pimozide—Headache—Vinorelbine—ovarian cancer	0.000261	0.00183	CcSEcCtD
Pimozide—Syncope—Docetaxel—ovarian cancer	0.000261	0.00183	CcSEcCtD
Pimozide—Dysphagia—Doxorubicin—ovarian cancer	0.000261	0.00182	CcSEcCtD
Pimozide—Leukopenia—Docetaxel—ovarian cancer	0.000261	0.00182	CcSEcCtD
Pimozide—Pollakiuria—Epirubicin—ovarian cancer	0.000261	0.00182	CcSEcCtD
Pimozide—Eosinophilia—Doxorubicin—ovarian cancer	0.000259	0.0018	CcSEcCtD
Pimozide—Palpitations—Docetaxel—ovarian cancer	0.000258	0.0018	CcSEcCtD
Pimozide—Weight increased—Epirubicin—ovarian cancer	0.000257	0.00179	CcSEcCtD
Pimozide—Loss of consciousness—Docetaxel—ovarian cancer	0.000256	0.00179	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000256	0.00179	CcSEcCtD
Pimozide—Weight decreased—Epirubicin—ovarian cancer	0.000255	0.00178	CcSEcCtD
Pimozide—Insomnia—Paclitaxel—ovarian cancer	0.000254	0.00177	CcSEcCtD
Pimozide—Convulsion—Docetaxel—ovarian cancer	0.000253	0.00176	CcSEcCtD
Pimozide—Hypertension—Docetaxel—ovarian cancer	0.000252	0.00176	CcSEcCtD
Pimozide—Drowsiness—Epirubicin—ovarian cancer	0.000252	0.00176	CcSEcCtD
Pimozide—Somnolence—Paclitaxel—ovarian cancer	0.00025	0.00174	CcSEcCtD
Pimozide—Chest pain—Docetaxel—ovarian cancer	0.000248	0.00173	CcSEcCtD
Pimozide—Myalgia—Docetaxel—ovarian cancer	0.000248	0.00173	CcSEcCtD
Pimozide—Pancytopenia—Doxorubicin—ovarian cancer	0.000248	0.00173	CcSEcCtD
Pimozide—Nausea—Vinorelbine—ovarian cancer	0.000248	0.00173	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000246	0.00172	CcSEcCtD
Pimozide—Decreased appetite—Paclitaxel—ovarian cancer	0.000244	0.0017	CcSEcCtD
Pimozide—Dry mouth—Docetaxel—ovarian cancer	0.000243	0.00169	CcSEcCtD
Pimozide—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000242	0.00169	CcSEcCtD
Pimozide—Sweating—Epirubicin—ovarian cancer	0.000241	0.00168	CcSEcCtD
Pimozide—Pollakiuria—Doxorubicin—ovarian cancer	0.000241	0.00168	CcSEcCtD
Pimozide—Constipation—Paclitaxel—ovarian cancer	0.00024	0.00168	CcSEcCtD
Pimozide—Weight increased—Doxorubicin—ovarian cancer	0.000238	0.00166	CcSEcCtD
Pimozide—ABCB1—testis—ovarian cancer	0.000237	0.00326	CbGeAlD
Pimozide—Weight decreased—Doxorubicin—ovarian cancer	0.000236	0.00165	CcSEcCtD
Pimozide—Agranulocytosis—Epirubicin—ovarian cancer	0.000235	0.00164	CcSEcCtD
Pimozide—Shock—Docetaxel—ovarian cancer	0.000234	0.00163	CcSEcCtD
Pimozide—Nervous system disorder—Docetaxel—ovarian cancer	0.000233	0.00163	CcSEcCtD
Pimozide—Drowsiness—Doxorubicin—ovarian cancer	0.000233	0.00163	CcSEcCtD
Pimozide—Tachycardia—Docetaxel—ovarian cancer	0.000232	0.00162	CcSEcCtD
Pimozide—Skin disorder—Docetaxel—ovarian cancer	0.000231	0.00161	CcSEcCtD
Pimozide—Anorexia—Docetaxel—ovarian cancer	0.000227	0.00158	CcSEcCtD
Pimozide—Sweating—Doxorubicin—ovarian cancer	0.000223	0.00156	CcSEcCtD
Pimozide—Urticaria—Paclitaxel—ovarian cancer	0.000223	0.00156	CcSEcCtD
Pimozide—Hypotension—Docetaxel—ovarian cancer	0.000222	0.00155	CcSEcCtD
Pimozide—Connective tissue disorder—Epirubicin—ovarian cancer	0.000222	0.00155	CcSEcCtD
Pimozide—Visual impairment—Epirubicin—ovarian cancer	0.000218	0.00152	CcSEcCtD
Pimozide—Agranulocytosis—Doxorubicin—ovarian cancer	0.000217	0.00152	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000217	0.00151	CcSEcCtD
Pimozide—Insomnia—Docetaxel—ovarian cancer	0.000215	0.0015	CcSEcCtD
Pimozide—Somnolence—Docetaxel—ovarian cancer	0.000211	0.00148	CcSEcCtD
Pimozide—Eye disorder—Epirubicin—ovarian cancer	0.000211	0.00147	CcSEcCtD
Pimozide—Cardiac disorder—Epirubicin—ovarian cancer	0.00021	0.00146	CcSEcCtD
Pimozide—Decreased appetite—Docetaxel—ovarian cancer	0.000207	0.00144	CcSEcCtD
Pimozide—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000205	0.00143	CcSEcCtD
Pimozide—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000205	0.00143	CcSEcCtD
Pimozide—Constipation—Docetaxel—ovarian cancer	0.000203	0.00142	CcSEcCtD
Pimozide—Visual impairment—Doxorubicin—ovarian cancer	0.000201	0.00141	CcSEcCtD
Pimozide—Asthenia—Paclitaxel—ovarian cancer	0.000201	0.00141	CcSEcCtD
Pimozide—Pruritus—Paclitaxel—ovarian cancer	0.000199	0.00139	CcSEcCtD
Pimozide—Mental disorder—Epirubicin—ovarian cancer	0.000198	0.00138	CcSEcCtD
Pimozide—Eye disorder—Doxorubicin—ovarian cancer	0.000195	0.00136	CcSEcCtD
Pimozide—Cardiac disorder—Doxorubicin—ovarian cancer	0.000194	0.00135	CcSEcCtD
Pimozide—Diarrhoea—Paclitaxel—ovarian cancer	0.000192	0.00134	CcSEcCtD
Pimozide—Muscle spasms—Epirubicin—ovarian cancer	0.000189	0.00132	CcSEcCtD
Pimozide—Dizziness—Paclitaxel—ovarian cancer	0.000186	0.0013	CcSEcCtD
Pimozide—Vision blurred—Epirubicin—ovarian cancer	0.000185	0.00129	CcSEcCtD
Pimozide—Mental disorder—Doxorubicin—ovarian cancer	0.000183	0.00128	CcSEcCtD
Pimozide—Anaemia—Epirubicin—ovarian cancer	0.000182	0.00127	CcSEcCtD
Pimozide—Agitation—Epirubicin—ovarian cancer	0.000181	0.00126	CcSEcCtD
Pimozide—Vomiting—Paclitaxel—ovarian cancer	0.000178	0.00125	CcSEcCtD
Pimozide—Rash—Paclitaxel—ovarian cancer	0.000177	0.00124	CcSEcCtD
Pimozide—Dermatitis—Paclitaxel—ovarian cancer	0.000177	0.00123	CcSEcCtD
Pimozide—Syncope—Epirubicin—ovarian cancer	0.000176	0.00123	CcSEcCtD
Pimozide—Leukopenia—Epirubicin—ovarian cancer	0.000176	0.00123	CcSEcCtD
Pimozide—Headache—Paclitaxel—ovarian cancer	0.000176	0.00123	CcSEcCtD
Pimozide—Muscle spasms—Doxorubicin—ovarian cancer	0.000175	0.00122	CcSEcCtD
Pimozide—Palpitations—Epirubicin—ovarian cancer	0.000174	0.00121	CcSEcCtD
Pimozide—Loss of consciousness—Epirubicin—ovarian cancer	0.000173	0.00121	CcSEcCtD
Pimozide—ABCB1—lymph node—ovarian cancer	0.000172	0.00236	CbGeAlD
Pimozide—Vision blurred—Doxorubicin—ovarian cancer	0.000171	0.0012	CcSEcCtD
Pimozide—Asthenia—Docetaxel—ovarian cancer	0.000171	0.00119	CcSEcCtD
Pimozide—Convulsion—Epirubicin—ovarian cancer	0.00017	0.00119	CcSEcCtD
Pimozide—Hypertension—Epirubicin—ovarian cancer	0.00017	0.00119	CcSEcCtD
Pimozide—Pruritus—Docetaxel—ovarian cancer	0.000168	0.00118	CcSEcCtD
Pimozide—Anaemia—Doxorubicin—ovarian cancer	0.000168	0.00117	CcSEcCtD
Pimozide—Chest pain—Epirubicin—ovarian cancer	0.000167	0.00117	CcSEcCtD
Pimozide—Myalgia—Epirubicin—ovarian cancer	0.000167	0.00117	CcSEcCtD
Pimozide—Agitation—Doxorubicin—ovarian cancer	0.000167	0.00117	CcSEcCtD
Pimozide—Nausea—Paclitaxel—ovarian cancer	0.000167	0.00116	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000166	0.00116	CcSEcCtD
Pimozide—Dry mouth—Epirubicin—ovarian cancer	0.000164	0.00114	CcSEcCtD
Pimozide—Syncope—Doxorubicin—ovarian cancer	0.000163	0.00114	CcSEcCtD
Pimozide—Leukopenia—Doxorubicin—ovarian cancer	0.000163	0.00114	CcSEcCtD
Pimozide—Diarrhoea—Docetaxel—ovarian cancer	0.000163	0.00114	CcSEcCtD
Pimozide—Palpitations—Doxorubicin—ovarian cancer	0.000161	0.00112	CcSEcCtD
Pimozide—Loss of consciousness—Doxorubicin—ovarian cancer	0.00016	0.00112	CcSEcCtD
Pimozide—Shock—Epirubicin—ovarian cancer	0.000158	0.0011	CcSEcCtD
Pimozide—Convulsion—Doxorubicin—ovarian cancer	0.000158	0.0011	CcSEcCtD
Pimozide—Nervous system disorder—Epirubicin—ovarian cancer	0.000157	0.0011	CcSEcCtD
Pimozide—Dizziness—Docetaxel—ovarian cancer	0.000157	0.0011	CcSEcCtD
Pimozide—Hypertension—Doxorubicin—ovarian cancer	0.000157	0.0011	CcSEcCtD
Pimozide—Tachycardia—Epirubicin—ovarian cancer	0.000157	0.00109	CcSEcCtD
Pimozide—Skin disorder—Epirubicin—ovarian cancer	0.000156	0.00109	CcSEcCtD
Pimozide—Hyperhidrosis—Epirubicin—ovarian cancer	0.000155	0.00108	CcSEcCtD
Pimozide—Chest pain—Doxorubicin—ovarian cancer	0.000155	0.00108	CcSEcCtD
Pimozide—Myalgia—Doxorubicin—ovarian cancer	0.000155	0.00108	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000154	0.00107	CcSEcCtD
Pimozide—Anorexia—Epirubicin—ovarian cancer	0.000153	0.00107	CcSEcCtD
Pimozide—Dry mouth—Doxorubicin—ovarian cancer	0.000151	0.00106	CcSEcCtD
Pimozide—Vomiting—Docetaxel—ovarian cancer	0.000151	0.00106	CcSEcCtD
Pimozide—Rash—Docetaxel—ovarian cancer	0.00015	0.00105	CcSEcCtD
Pimozide—Hypotension—Epirubicin—ovarian cancer	0.00015	0.00105	CcSEcCtD
Pimozide—Dermatitis—Docetaxel—ovarian cancer	0.00015	0.00105	CcSEcCtD
Pimozide—Headache—Docetaxel—ovarian cancer	0.000149	0.00104	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000146	0.00102	CcSEcCtD
Pimozide—Shock—Doxorubicin—ovarian cancer	0.000146	0.00102	CcSEcCtD
Pimozide—Nervous system disorder—Doxorubicin—ovarian cancer	0.000146	0.00102	CcSEcCtD
Pimozide—Insomnia—Epirubicin—ovarian cancer	0.000145	0.00101	CcSEcCtD
Pimozide—Tachycardia—Doxorubicin—ovarian cancer	0.000145	0.00101	CcSEcCtD
Pimozide—Skin disorder—Doxorubicin—ovarian cancer	0.000144	0.00101	CcSEcCtD
Pimozide—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000144	0.001	CcSEcCtD
Pimozide—Somnolence—Epirubicin—ovarian cancer	0.000143	0.000996	CcSEcCtD
Pimozide—Anorexia—Doxorubicin—ovarian cancer	0.000142	0.000988	CcSEcCtD
Pimozide—Nausea—Docetaxel—ovarian cancer	0.000141	0.000987	CcSEcCtD
Pimozide—Decreased appetite—Epirubicin—ovarian cancer	0.000139	0.000974	CcSEcCtD
Pimozide—Hypotension—Doxorubicin—ovarian cancer	0.000139	0.000969	CcSEcCtD
Pimozide—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000139	0.000967	CcSEcCtD
Pimozide—Constipation—Epirubicin—ovarian cancer	0.000137	0.000958	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000135	0.000944	CcSEcCtD
Pimozide—Insomnia—Doxorubicin—ovarian cancer	0.000134	0.000938	CcSEcCtD
Pimozide—Somnolence—Doxorubicin—ovarian cancer	0.000132	0.000922	CcSEcCtD
Pimozide—Decreased appetite—Doxorubicin—ovarian cancer	0.000129	0.000901	CcSEcCtD
Pimozide—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000128	0.000895	CcSEcCtD
Pimozide—Urticaria—Epirubicin—ovarian cancer	0.000127	0.00089	CcSEcCtD
Pimozide—Constipation—Doxorubicin—ovarian cancer	0.000127	0.000886	CcSEcCtD
Pimozide—Urticaria—Doxorubicin—ovarian cancer	0.000118	0.000823	CcSEcCtD
Pimozide—Asthenia—Epirubicin—ovarian cancer	0.000115	0.000804	CcSEcCtD
Pimozide—Pruritus—Epirubicin—ovarian cancer	0.000114	0.000793	CcSEcCtD
Pimozide—Diarrhoea—Epirubicin—ovarian cancer	0.00011	0.000767	CcSEcCtD
Pimozide—Asthenia—Doxorubicin—ovarian cancer	0.000107	0.000744	CcSEcCtD
Pimozide—Dizziness—Epirubicin—ovarian cancer	0.000106	0.000741	CcSEcCtD
Pimozide—Pruritus—Doxorubicin—ovarian cancer	0.000105	0.000733	CcSEcCtD
Pimozide—Vomiting—Epirubicin—ovarian cancer	0.000102	0.000712	CcSEcCtD
Pimozide—Diarrhoea—Doxorubicin—ovarian cancer	0.000102	0.000709	CcSEcCtD
Pimozide—Rash—Epirubicin—ovarian cancer	0.000101	0.000706	CcSEcCtD
Pimozide—Dermatitis—Epirubicin—ovarian cancer	0.000101	0.000706	CcSEcCtD
Pimozide—Headache—Epirubicin—ovarian cancer	0.000101	0.000702	CcSEcCtD
Pimozide—Dizziness—Doxorubicin—ovarian cancer	9.82e-05	0.000685	CcSEcCtD
Pimozide—Nausea—Epirubicin—ovarian cancer	9.53e-05	0.000665	CcSEcCtD
Pimozide—Vomiting—Doxorubicin—ovarian cancer	9.44e-05	0.000659	CcSEcCtD
Pimozide—Rash—Doxorubicin—ovarian cancer	9.36e-05	0.000654	CcSEcCtD
Pimozide—Dermatitis—Doxorubicin—ovarian cancer	9.35e-05	0.000653	CcSEcCtD
Pimozide—Headache—Doxorubicin—ovarian cancer	9.3e-05	0.000649	CcSEcCtD
Pimozide—Nausea—Doxorubicin—ovarian cancer	8.82e-05	0.000616	CcSEcCtD
Pimozide—DRD2—Signaling by GPCR—AKT1—ovarian cancer	5.38e-06	3.77e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—PIK3CA—ovarian cancer	5.38e-06	3.77e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—IL6—ovarian cancer	5.38e-06	3.77e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MAPK3—ovarian cancer	5.37e-06	3.76e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MMP9—ovarian cancer	5.36e-06	3.75e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—KRAS—ovarian cancer	5.35e-06	3.75e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—MYC—ovarian cancer	5.35e-06	3.74e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—PTEN—ovarian cancer	5.33e-06	3.73e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—MAPK3—ovarian cancer	5.32e-06	3.72e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—MAPK3—ovarian cancer	5.32e-06	3.72e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—IL6—ovarian cancer	5.3e-06	3.71e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—AKT1—ovarian cancer	5.29e-06	3.71e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—AKT1—ovarian cancer	5.28e-06	3.7e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—ERBB2—ovarian cancer	5.28e-06	3.7e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—PIK3CA—ovarian cancer	5.28e-06	3.7e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ABCB1—ovarian cancer	5.27e-06	3.69e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—MAPK1—ovarian cancer	5.23e-06	3.66e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—EGFR—ovarian cancer	5.23e-06	3.66e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MYC—ovarian cancer	5.22e-06	3.66e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MTOR—ovarian cancer	5.21e-06	3.65e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PIK3CB—ovarian cancer	5.21e-06	3.65e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PTEN—ovarian cancer	5.21e-06	3.65e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PTEN—ovarian cancer	5.21e-06	3.65e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—PIK3CA—ovarian cancer	5.2e-06	3.64e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—PIK3CA—ovarian cancer	5.2e-06	3.64e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—AKT1—ovarian cancer	5.2e-06	3.64e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—TYMS—ovarian cancer	5.18e-06	3.63e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—KRAS—ovarian cancer	5.17e-06	3.62e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—KRAS—ovarian cancer	5.17e-06	3.62e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—MYC—ovarian cancer	5.17e-06	3.62e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—MYC—ovarian cancer	5.17e-06	3.62e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.16e-06	3.62e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—PIK3CA—ovarian cancer	5.13e-06	3.6e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—ERBB2—ovarian cancer	5.11e-06	3.58e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—ERBB2—ovarian cancer	5.11e-06	3.58e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CD—ovarian cancer	5.11e-06	3.58e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MAPK1—ovarian cancer	5.11e-06	3.58e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—EGFR—ovarian cancer	5.11e-06	3.58e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—PIK3CA—ovarian cancer	5.08e-06	3.56e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—MAPK1—ovarian cancer	5.06e-06	3.54e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—MAPK1—ovarian cancer	5.06e-06	3.54e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—EGFR—ovarian cancer	5.06e-06	3.54e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—EGFR—ovarian cancer	5.06e-06	3.54e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PIK3CB—ovarian cancer	5.04e-06	3.53e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MTOR—ovarian cancer	5.04e-06	3.53e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MTOR—ovarian cancer	5.04e-06	3.53e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PIK3CB—ovarian cancer	5.04e-06	3.53e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CXCL8—ovarian cancer	5.01e-06	3.51e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—VEGFA—ovarian cancer	4.98e-06	3.49e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—HRAS—ovarian cancer	4.98e-06	3.49e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TP53—ovarian cancer	4.97e-06	3.48e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—AKT1—ovarian cancer	4.96e-06	3.48e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—KRAS—ovarian cancer	4.94e-06	3.46e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—STAT3—ovarian cancer	4.93e-06	3.45e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CG—ovarian cancer	4.92e-06	3.45e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—NRAS—ovarian cancer	4.92e-06	3.45e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TP53—ovarian cancer	4.92e-06	3.45e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—PIK3CA—ovarian cancer	4.91e-06	3.44e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—VEGFA—ovarian cancer	4.9e-06	3.43e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CDKN1B—ovarian cancer	4.89e-06	3.43e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—VEGFA—ovarian cancer	4.89e-06	3.43e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—AKT1—ovarian cancer	4.89e-06	3.43e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—STAT3—ovarian cancer	4.85e-06	3.4e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CXCL8—ovarian cancer	4.85e-06	3.39e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CXCL8—ovarian cancer	4.85e-06	3.39e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—STAT3—ovarian cancer	4.84e-06	3.39e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—NRAS—ovarian cancer	4.84e-06	3.39e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3CB—ovarian cancer	4.84e-06	3.39e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—NRAS—ovarian cancer	4.83e-06	3.38e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—KRAS—ovarian cancer	4.82e-06	3.38e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—HRAS—ovarian cancer	4.81e-06	3.37e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—HRAS—ovarian cancer	4.81e-06	3.37e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—VEGFA—ovarian cancer	4.81e-06	3.37e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CASP3—ovarian cancer	4.79e-06	3.36e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL2—ovarian cancer	4.79e-06	3.35e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—KRAS—ovarian cancer	4.78e-06	3.35e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—KRAS—ovarian cancer	4.78e-06	3.35e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—STAT3—ovarian cancer	4.76e-06	3.34e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—IL6—ovarian cancer	4.76e-06	3.34e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—PIK3CA—ovarian cancer	4.75e-06	3.33e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—PIK3CA—ovarian cancer	4.75e-06	3.33e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—NRAS—ovarian cancer	4.75e-06	3.33e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—HRAS—ovarian cancer	4.75e-06	3.33e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CDKN1B—ovarian cancer	4.73e-06	3.31e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CDKN1B—ovarian cancer	4.73e-06	3.31e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3CB—ovarian cancer	4.72e-06	3.31e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MAPK3—ovarian cancer	4.71e-06	3.3e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—HRAS—ovarian cancer	4.7e-06	3.29e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCND1—ovarian cancer	4.67e-06	3.27e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CASP3—ovarian cancer	4.64e-06	3.25e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CASP3—ovarian cancer	4.64e-06	3.25e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MAPK3—ovarian cancer	4.64e-06	3.25e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL2—ovarian cancer	4.63e-06	3.24e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL2—ovarian cancer	4.63e-06	3.24e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MAPK3—ovarian cancer	4.63e-06	3.24e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CTNNB1—ovarian cancer	4.62e-06	3.24e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL6—ovarian cancer	4.61e-06	3.23e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL6—ovarian cancer	4.61e-06	3.23e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MYC—ovarian cancer	4.58e-06	3.21e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MAPK3—ovarian cancer	4.55e-06	3.19e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—HRAS—ovarian cancer	4.55e-06	3.19e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL6—ovarian cancer	4.55e-06	3.18e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—PIK3CA—ovarian cancer	4.54e-06	3.18e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MMP9—ovarian cancer	4.53e-06	3.17e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCND1—ovarian cancer	4.51e-06	3.16e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCND1—ovarian cancer	4.51e-06	3.16e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MYC—ovarian cancer	4.51e-06	3.16e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PTEN—ovarian cancer	4.5e-06	3.16e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL6—ovarian cancer	4.5e-06	3.15e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MYC—ovarian cancer	4.5e-06	3.15e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MAPK1—ovarian cancer	4.48e-06	3.14e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—EGFR—ovarian cancer	4.48e-06	3.14e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CTNNB1—ovarian cancer	4.47e-06	3.13e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CTNNB1—ovarian cancer	4.47e-06	3.13e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CB—ovarian cancer	4.45e-06	3.12e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—PIK3CA—ovarian cancer	4.43e-06	3.1e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MYC—ovarian cancer	4.43e-06	3.1e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MAPK1—ovarian cancer	4.41e-06	3.09e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—EGFR—ovarian cancer	4.41e-06	3.09e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MAPK1—ovarian cancer	4.4e-06	3.08e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—EGFR—ovarian cancer	4.4e-06	3.08e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—HRAS—ovarian cancer	4.4e-06	3.08e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—HRAS—ovarian cancer	4.4e-06	3.08e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—AKT1—ovarian cancer	4.39e-06	3.08e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—PIK3CA—ovarian cancer	4.39e-06	3.07e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—PIK3CA—ovarian cancer	4.39e-06	3.07e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MMP9—ovarian cancer	4.38e-06	3.07e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MMP9—ovarian cancer	4.38e-06	3.07e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PTEN—ovarian cancer	4.36e-06	3.05e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PTEN—ovarian cancer	4.36e-06	3.05e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL6—ovarian cancer	4.35e-06	3.05e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MAPK1—ovarian cancer	4.33e-06	3.03e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—EGFR—ovarian cancer	4.33e-06	3.03e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CD—ovarian cancer	4.33e-06	3.03e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—AKT1—ovarian cancer	4.31e-06	3.02e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TP53—ovarian cancer	4.29e-06	3e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—AKT1—ovarian cancer	4.25e-06	2.98e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—AKT1—ovarian cancer	4.25e-06	2.98e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—KRAS—ovarian cancer	4.23e-06	2.97e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL6—ovarian cancer	4.21e-06	2.95e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL6—ovarian cancer	4.21e-06	2.95e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—HRAS—ovarian cancer	4.2e-06	2.94e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—AKT1—ovarian cancer	4.19e-06	2.94e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PTEN—ovarian cancer	4.18e-06	2.93e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CAV1—ovarian cancer	4.17e-06	2.92e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—KRAS—ovarian cancer	4.17e-06	2.92e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—KRAS—ovarian cancer	4.16e-06	2.91e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—AKT1—ovarian cancer	4.15e-06	2.91e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—HRAS—ovarian cancer	4.1e-06	2.87e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—KRAS—ovarian cancer	4.09e-06	2.87e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PTEN—ovarian cancer	4.08e-06	2.86e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—VEGFA—ovarian cancer	4.07e-06	2.85e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—HRAS—ovarian cancer	4.06e-06	2.84e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—HRAS—ovarian cancer	4.06e-06	2.84e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—STAT3—ovarian cancer	4.03e-06	2.82e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—NRAS—ovarian cancer	4.02e-06	2.81e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—IL6—ovarian cancer	4.02e-06	2.81e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—AKT1—ovarian cancer	4.02e-06	2.81e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—VEGFA—ovarian cancer	3.94e-06	2.76e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—VEGFA—ovarian cancer	3.94e-06	2.76e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL6—ovarian cancer	3.92e-06	2.75e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—STAT3—ovarian cancer	3.9e-06	2.73e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—STAT3—ovarian cancer	3.9e-06	2.73e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—PIK3CA—ovarian cancer	3.89e-06	2.73e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—NRAS—ovarian cancer	3.89e-06	2.72e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—NRAS—ovarian cancer	3.89e-06	2.72e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—IL6—ovarian cancer	3.89e-06	2.72e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—IL6—ovarian cancer	3.89e-06	2.72e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—AKT1—ovarian cancer	3.88e-06	2.72e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—AKT1—ovarian cancer	3.88e-06	2.72e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MAPK3—ovarian cancer	3.85e-06	2.7e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PTEN—ovarian cancer	3.85e-06	2.69e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—PIK3CA—ovarian cancer	3.83e-06	2.68e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PIK3CA—ovarian cancer	3.82e-06	2.68e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—PIK3CA—ovarian cancer	3.82e-06	2.68e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PIK3CA—ovarian cancer	3.82e-06	2.67e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PIK3CA—ovarian cancer	3.8e-06	2.66e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.8e-06	2.66e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CB—ovarian cancer	3.77e-06	2.64e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TP53—ovarian cancer	3.76e-06	2.64e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—PIK3CA—ovarian cancer	3.76e-06	2.63e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MYC—ovarian cancer	3.74e-06	2.62e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MAPK3—ovarian cancer	3.72e-06	2.61e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MAPK3—ovarian cancer	3.72e-06	2.61e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—AKT1—ovarian cancer	3.71e-06	2.6e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TP53—ovarian cancer	3.7e-06	2.59e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TP53—ovarian cancer	3.7e-06	2.59e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PIK3CA—ovarian cancer	3.68e-06	2.57e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PIK3CA—ovarian cancer	3.68e-06	2.57e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MAPK1—ovarian cancer	3.66e-06	2.57e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—EGFR—ovarian cancer	3.66e-06	2.56e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TP53—ovarian cancer	3.64e-06	2.55e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MYC—ovarian cancer	3.62e-06	2.54e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MYC—ovarian cancer	3.62e-06	2.54e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—AKT1—ovarian cancer	3.62e-06	2.54e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—HRAS—ovarian cancer	3.6e-06	2.52e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—AKT1—ovarian cancer	3.59e-06	2.51e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—AKT1—ovarian cancer	3.59e-06	2.51e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MAPK1—ovarian cancer	3.54e-06	2.48e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MAPK1—ovarian cancer	3.54e-06	2.48e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—EGFR—ovarian cancer	3.54e-06	2.48e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—EGFR—ovarian cancer	3.54e-06	2.48e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—HRAS—ovarian cancer	3.54e-06	2.48e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—HRAS—ovarian cancer	3.53e-06	2.48e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—HRAS—ovarian cancer	3.48e-06	2.44e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—KRAS—ovarian cancer	3.46e-06	2.42e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL6—ovarian cancer	3.45e-06	2.41e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL6—ovarian cancer	3.39e-06	2.37e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL6—ovarian cancer	3.38e-06	2.37e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—KRAS—ovarian cancer	3.35e-06	2.34e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—KRAS—ovarian cancer	3.35e-06	2.34e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CD—ovarian cancer	3.34e-06	2.34e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL6—ovarian cancer	3.33e-06	2.33e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PTEN—ovarian cancer	3.26e-06	2.28e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—AKT1—ovarian cancer	3.18e-06	2.23e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PIK3CA—ovarian cancer	3.18e-06	2.23e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—AKT1—ovarian cancer	3.13e-06	2.19e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—AKT1—ovarian cancer	3.12e-06	2.19e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—AKT1—ovarian cancer	3.12e-06	2.19e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—AKT1—ovarian cancer	3.12e-06	2.18e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—AKT1—ovarian cancer	3.1e-06	2.17e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TP53—ovarian cancer	3.07e-06	2.15e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PIK3CA—ovarian cancer	3.07e-06	2.15e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PIK3CA—ovarian cancer	3.07e-06	2.15e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—AKT1—ovarian cancer	3.07e-06	2.15e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—AKT1—ovarian cancer	3e-06	2.1e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—AKT1—ovarian cancer	3e-06	2.1e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TP53—ovarian cancer	2.97e-06	2.08e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TP53—ovarian cancer	2.97e-06	2.08e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3CA—ovarian cancer	2.95e-06	2.07e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—HRAS—ovarian cancer	2.94e-06	2.06e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.91e-06	2.04e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3CA—ovarian cancer	2.88e-06	2.02e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—HRAS—ovarian cancer	2.84e-06	1.99e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—HRAS—ovarian cancer	2.84e-06	1.99e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL6—ovarian cancer	2.81e-06	1.97e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL6—ovarian cancer	2.72e-06	1.91e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL6—ovarian cancer	2.72e-06	1.91e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CA—ovarian cancer	2.71e-06	1.9e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—AKT1—ovarian cancer	2.6e-06	1.82e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PTEN—ovarian cancer	2.52e-06	1.76e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—AKT1—ovarian cancer	2.51e-06	1.76e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—AKT1—ovarian cancer	2.51e-06	1.76e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—AKT1—ovarian cancer	2.41e-06	1.69e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—AKT1—ovarian cancer	2.35e-06	1.65e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CA—ovarian cancer	2.3e-06	1.61e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—AKT1—ovarian cancer	2.22e-06	1.55e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—AKT1—ovarian cancer	1.88e-06	1.32e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.77e-06	1.24e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—AKT1—ovarian cancer	1.45e-06	1.02e-05	CbGpPWpGaD
